Company: MLSS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022276
Chunk: 115

Company: MILESTONE SCIENTIFIC INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 3
Chunk 115
---
Milestone
Scientific is a “smaller reporting company” as defined by Regulation S-K and, as such, is not required to provide the information
required by this item.

Item
4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and
Principal Accounting Officer, evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2025. The term
“disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934,
as amended (the “Exchange Act”), refers to controls and other procedures designed to ensure that information required to be
disclosed by a company in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the
time periods specified in the SEC’s rules and forms.

Disclosure controls and procedures include, without limitation, controls
and procedures designed to ensure that information required to be disclosed by a company is accumulated and communicated to management,
including the principal executive and principal financial officers (or persons performing similar functions), as appropriate, to allow
timely decisions regarding required disclosure.

Management recognizes that any system of controls and procedures, no matter
how well designed and operated, can provide only reasonable assurance of achieving its objectives. Accordingly, management must apply
judgment in evaluating the cost-benefit relationship of potential control enhancements. Based on their evaluation, our Chief Executive
Officer and Principal Accounting Officer concluded that, as of September 30, 2025, our disclosure controls and procedures were effective
at a reasonable assurance level.

Changes in Internal Control over Financial Reporting

We routinely review and evaluate our internal control over financial reporting
and periodically make changes intended to enhance its effectiveness. During the quarter ended September 30, 2025, there were no changes
in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, that materially
affected, or are reasonably likely to materially affect, our internal control over financial reporting. 

 26 

Item
1A. Risk Factors

Except
as disclosed below, there have been no material changes to the risk factors previously disclosed in Part I, Item 1A, of our 2024 Annual
Report.

Changes
to United States tariff and import/export regulations may have a material adverse effect on our business, financial condition, and